Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults

被引:119
|
作者
Nakamura, M
Konishi, N
Tsunoda, S
Nakase, H
Tsuzuki, T
Aoki, H
Sakitani, H
Inui, T
Sakaki, T
机构
[1] Nara Med Univ, Dept Neurosurg, Nara 6348521, Japan
[2] Nara Med Univ, Dept Pathol 2, Nara 6348521, Japan
关键词
astrocytoma; low-grade; radiation; p53; prognosis; survival; radical surgery;
D O I
10.1159/000012087
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prognostic factors for low-grade astrocytomas have been proposed, but optimal treatment remains controversial. Eighty-eight consecutive adult patients with supratentorial low-grade astrocytomas were retrospectively reviewed to determine specific factors influencing outcome. All underwent craniotomy (43 radical resections, 45 nonradical resections). Sex, age at diagnosis, preoperative Karnofsky performance status (KPS), tumor location, estimated extent of resection, radiation, chemotherapy, histological type, p53 status, MIB-1 staining and the apoptotic index were assessed as parameters for prognostic significance. KPS (p = 0.03), tumor location (p < 0.001), extent of surgical resection (p < 0.001) and radiotherapy (p = 0.01) were significantly assoicated with longer survival rates by univariate analysis. Multivariate analysis also showed a significant correlation between radiation therapy after surgical removal and survival time (p < 0.001), p53 status was not of importance in determining the necessity for radiotherapy. Radical surgical removal is the most important factor in the management of low-grade astrocytomas. Radiation therapy appears to be effective in improving the prognosis regardless of the extent of surgical resection or the p53 status. Copyright (C) 2000 S. Karger AG, Basel
引用
收藏
页码:108 / 116
页数:9
相关论文
共 50 条
  • [31] Low-grade astrocytomas in children: Evolving management strategies
    Freeman, CR
    Farmer, JP
    Montes, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (05): : 979 - 987
  • [32] PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN LOW-GRADE ASTROCYTOMAS - ITS PROGNOSTIC-SIGNIFICANCE
    VIGLIANI, MC
    CHIO, A
    PEZZULO, T
    SOFFIETTI, R
    GIORDANA, MT
    SCHIFFER, D
    TUMORI, 1994, 80 (04) : 295 - 300
  • [33] Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature
    Chaichana, Kaisorn L.
    McGirt, Matthew J.
    Niranjan, Ashwini
    Olivi, Alessandro
    Burger, Peter C.
    Quinones-Hinojosa, Alfredo
    NEUROLOGICAL RESEARCH, 2009, 31 (09) : 931 - 939
  • [34] Immunological and prognostic analysis of PSENEN in low-grade gliomas: An immune infiltration-related prognostic biomarker
    Chen, Kaijie
    Liang, Beibei
    Ma, Wenhao
    Wan, Guoqing
    Chen, Bing
    Lu, Changlian
    Luo, Yuzhou
    Gu, Xuefeng
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [35] Low grade supratentorial astrocytomas in adults: Management, immunohistochemical analysis and long-term follow-up
    Malham, G
    Moonesinghe, S
    Synek, B
    Anderson, N
    Bok, A
    JOURNAL OF CLINICAL NEUROSCIENCE, 1998, 5 (03) : 304 - 309
  • [36] Prognostic Factors in Lobar World Health Organization Grade II Astrocytomas
    Waqar, Mueez
    Hanif, Shahid
    Brodbelt, Andrew R.
    Rathi, Nitika
    Das, Kumar
    Zakaria, Rasheed
    Walker, Carol
    Jenkinson, Michael D.
    WORLD NEUROSURGERY, 2015, 84 (01) : 154 - 162
  • [37] Low-grade gliomas in adults
    Sandeep Mittal
    Mark C. Szlaczky
    Geoffrey R. Barger
    Current Treatment Options in Neurology, 2008, 10 : 271 - 284
  • [38] Low-grade gliomas in adults
    Sanai, Nader
    Chang, Susan
    Berger, Mitchel S.
    JOURNAL OF NEUROSURGERY, 2011, 115 (05) : 948 - 965
  • [39] Low-grade gliomas in adults
    Grier, Jeanine T.
    Batchelor, Tracy
    ONCOLOGIST, 2006, 11 (06) : 681 - 693
  • [40] Low-grade gliomas in adults
    Dropcho E.J.
    Current Treatment Options in Neurology, 2004, 6 (4) : 265 - 271